George Van Antwerp breaks down how Prime is poised to drive affordability in drug pricing

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Prime Therapeutics experts share insights about the classification, cost and impact of these revolutionary drugs

In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event

In the latest episode of the “Pharmacy Friends” podcast, experts share how integrating medical and pharmacy benefits can close gaps in care, improve treatment decisions and help manage rising...

This form is specifically used to request a check reissue. For remittance requests, please use the following link: Pharmacy remittance request - Prime Therapeutics LLC. Prime Therapeutics cannot...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Disclaimer THIS WEBSITE IS AN OPTIONAL RESOURCE FOR HEALTH CARE PROVIDERS ONLY. IF YOU ARE NOT A HEALTH CARE PROVIDER OR AUTHORIZED PROFESSIONAL USER, YOU ARE NOT TO USE THIS SITE AT ALL AND ARE...

Category Migration Site ID Liferay Token Category Type Old Categories New Read Category Prime Article Type Dry Run - preview only, do not update content Migration UpdateType Migration Output Log

December 2024 December 2023 December 2021 Pharmacy newsletter from Prime Therapeutics that provides information and updates about Prime services. June 2022 Home Other Navigation Pharmacy +...

publications Fall 2024 Prime Therapeutics Report October 21, 2024 Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on...

Prime simplifies the cancer care pathway through innovative solutions that help manage complex conditions

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

July 17, 2026 publications 2026 Medical Pharmacy Trend Report: Part 2 – Drug Overview The 2026 Medical Pharmacy Trend Report: Part 2 – Drug Overview reflects Prime Therapeutics’ long‑standing...

NBC News: Patients weren't asked why they quit taking the weight loss drugs

Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.

Prime Therapeutics’ analysis of claims data suggests patients require support to ensure continued use and lifestyle modification

Most patients taking drugs such as Wegovy for weight loss discontinue usage within a year, according to Prime Therapeutics

Millions of people desperate to lose weight want to take Wegovy or its sister drug Ozempic

Insurers are using prior authorization and other managed care strategies to control costs associated with the growing number of prescriptions, on- and off-label, for the weight-loss medications